Keith Katkin, Director at Syndax Pharmaceuticals Inc (SNDX), bought 10,000 shares at $9.11 ($91K) on 2025-05-19, disclosed to the SEC on 2025-05-19.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| SNDX | SELL | 2022-10-07 | $1.5M | — | Filing → |
| SNDX | SELL | 2022-10-04 | $176K | — | Filing → |
| UROV | SELL | 2019-12-11 | $1.5M | — | Filing → |